Interacciones de Fentermina

Fentermina (Adipex-P, Lomaira), estimulante del SNC, tiene 196 interacciones documentadas en las etiquetas de la FDA y las hojas informativas que indexamos. Graves: 45; moderadas: 113; leves: 38; casos en los que una etiqueta indica que no hay ninguna interacción significativa: 0. Cada entrada de abajo cita la frase que la respalda. Esta página del medicamento es un punto de partida, no un veredicto sobre su situación.

Interacciones según la etiqueta

Interacciones graves (45)

  • AdrenalinasimpaticomiméticoGrave

    …states • History of drug abuse • Pregnancy [ see Use in Specific Populations () ] • Nursing [ see Use in Specific Populations ( 8.3 ) ] • Known hypersensitivity, or idiosyncrasy to the sympathomimetic amines • History of cardiovascular disease (e.g., coronary artery disease, stroke, arrhythmias, congestive heart failure, uncontrolled hypertension) () • During or within… (etiqueta de Fentermina, Contraindicaciones)

  • Anfetaminaestimulante del SNCGrave

    Hypersensitivity reactions such as angioedema and anaphylactic reactions have been reported in patients treated with other amphetamine products [ see Adverse Reactions (6) ] . (etiqueta de Anfetamina, Contraindicaciones)

  • Anfetamina y dexanfetaminaestimulante del SNCGrave

    Hypersensitivity reactions such as angioedema and anaphylactic reactions have been reported in patients treated with other amphetamine products [see Adverse Reactions ( 6.2 )] . taking monoamine oxidase inhibitors (MAOIs), or within 14 days of stopping MAOIs (including MAOIs such as linezolid or intravenous methylene blue), because of an increased risk of hypertensive… (etiqueta de Anfetamina y dexanfetamina, Contraindicaciones)

  • Arformoterolagonista beta-adrenérgicoGrave

    …states • History of drug abuse • Pregnancy [ see Use in Specific Populations () ] • Nursing [ see Use in Specific Populations ( 8.3 ) ] • Known hypersensitivity, or idiosyncrasy to the sympathomimetic amines • History of cardiovascular disease (e.g., coronary artery disease, stroke, arrhythmias, congestive heart failure, uncontrolled hypertension) () • During or within… (etiqueta de Fentermina, Contraindicaciones)

  • Azul de metilenoinhibidor de la MAOGrave

    …cardiovascular disease (e.g., coronary artery disease, stroke, arrhythmias, congestive heart failure, uncontrolled hypertension) • During or within 14 days following the administration of monoamine oxidase inhibitors • Hyperthyroidism • Glaucoma • Agitated states • History of drug abuse • Pregnancy [ see Use in Specific Populations () ] • Nursing [ see Use in Specific… (etiqueta de Fentermina, Contraindicaciones)

  • Benzfetaminaestimulante del SNCGrave

    Benzphetamine Hydrochloride Tablets should not be used concomitantly with other CNS stimulants. (etiqueta de Benzfetamina, Contraindicaciones)

  • …states • History of drug abuse • Pregnancy [ see Use in Specific Populations () ] • Nursing [ see Use in Specific Populations ( 8.3 ) ] • Known hypersensitivity, or idiosyncrasy to the sympathomimetic amines • History of cardiovascular disease (e.g., coronary artery disease, stroke, arrhythmias, congestive heart failure, uncontrolled hypertension) () • During or within… (etiqueta de Fentermina, Contraindicaciones)

  • Budesonida y formoterolcorticosteroideGrave

    …states • History of drug abuse • Pregnancy [ see Use in Specific Populations () ] • Nursing [ see Use in Specific Populations ( 8.3 ) ] • Known hypersensitivity, or idiosyncrasy to the sympathomimetic amines • History of cardiovascular disease (e.g., coronary artery disease, stroke, arrhythmias, congestive heart failure, uncontrolled hypertension) () • During or within… (etiqueta de Fentermina, Contraindicaciones)

  • Cloroprocaínaanestésico localGrave

    Vasopressors should not be used in the presence of ergot-type oxytocic drugs, since a severe persistent hypertension may occur. (etiqueta de Cloroprocaína, Advertencias)

  • Cocaínaanestésico localGrave

    WARNING: ABUSE AND DEPENDENCE CNS stimulants, including cocaine hydrochloride, have a high potential for abuse and dependence. (etiqueta de Cocaína, Advertencia en recuadro)

  • Dexanfetaminaestimulante del SNCGrave

    CONTRAINDICATIONS Advanced arteriosclerosis, symptomatic cardiovascular disease, moderate to severe hypertension, hyperthyroidism, known hypersensitivity or idiosyncrasy to the sympathomimetic amines, glaucoma. (etiqueta de Dexanfetamina, Contraindicaciones)

  • DronabinolcannabinoideGrave

    Avoid concomitant use of other drugs that are also associated with similar cardiac effects (e.g., amphetamines, other sympathomimetic agents, atropine, amoxapine, scopolamine, antihistamines, other anticholinergic agents, amitriptyline, desipramine, other tricyclic antidepressants). (etiqueta de Dronabinol, Advertencias y precauciones)

  • Fendimetrazinaestimulante del SNCGrave

    …hypertension) • During or within 14 days following the administration of monoamine oxidase inhibitors • Hyperthyroidism • Glaucoma • Agitated states • History of drug abuse • Pregnancy (see PRECAUTIONS, Pregnancy ) • Nursing • Use in combination with other anorectic agents or CNS stimulants • Known hypersensitivity or idiosyncratic reactions to sympathomimetics (etiqueta de Fendimetrazina, Contraindicaciones)

  • Fenelzinainhibidor de la MAOGrave

    …cardiovascular disease (e.g., coronary artery disease, stroke, arrhythmias, congestive heart failure, uncontrolled hypertension) • During or within 14 days following the administration of monoamine oxidase inhibitors • Hyperthyroidism • Glaucoma • Agitated states • History of drug abuse • Pregnancy [ see Use in Specific Populations () ] • Nursing [ see Use in Specific… (etiqueta de Fentermina, Contraindicaciones)

  • FenilefrinadescongestionanteGrave

    …states • History of drug abuse • Pregnancy [ see Use in Specific Populations () ] • Nursing [ see Use in Specific Populations ( 8.3 ) ] • Known hypersensitivity, or idiosyncrasy to the sympathomimetic amines • History of cardiovascular disease (e.g., coronary artery disease, stroke, arrhythmias, congestive heart failure, uncontrolled hypertension) () • During or within… (etiqueta de Fentermina, Contraindicaciones)

  • Fentermina y topiramatoestimulante del SNCGrave

    …(8.1) ] With glaucoma [see Warnings and Precautions (5.3) ] With hyperthyroidism Taking or within 14 days of stopping a monoamine oxidase inhibitors [see Drug Interactions (7) ] With known hypersensitivity to phentermine, topiramate or any of the excipients in phentermine and topiramate extended-release capsules, or idiosyncrasy to the sympathomimetic amines. (etiqueta de Fentermina y topiramato, Contraindicaciones)

  • Fluticasona y salmeterolcorticosteroideGrave

    …states • History of drug abuse • Pregnancy [ see Use in Specific Populations () ] • Nursing [ see Use in Specific Populations ( 8.3 ) ] • Known hypersensitivity, or idiosyncrasy to the sympathomimetic amines • History of cardiovascular disease (e.g., coronary artery disease, stroke, arrhythmias, congestive heart failure, uncontrolled hypertension) () • During or within… (etiqueta de Fentermina, Contraindicaciones)

  • Formoterolagonista beta-adrenérgicoGrave

    …states • History of drug abuse • Pregnancy [ see Use in Specific Populations () ] • Nursing [ see Use in Specific Populations ( 8.3 ) ] • Known hypersensitivity, or idiosyncrasy to the sympathomimetic amines • History of cardiovascular disease (e.g., coronary artery disease, stroke, arrhythmias, congestive heart failure, uncontrolled hypertension) () • During or within… (etiqueta de Fentermina, Contraindicaciones)

  • Imipraminaantidepresivo tricíclicoGrave

    Avoid the use of preparations, such as decongestants and local anesthetics, that contain any sympathomimetic amine (e.g., epinephrine, norepinephrine), since it has been reported that tricyclic antidepressants can potentiate the effects of catecholamines. (etiqueta de Imipramina, Interacciones medicamentosas)

  • Ipratropio y salbutamolanticolinérgicoGrave

    …states • History of drug abuse • Pregnancy [ see Use in Specific Populations () ] • Nursing [ see Use in Specific Populations ( 8.3 ) ] • Known hypersensitivity, or idiosyncrasy to the sympathomimetic amines • History of cardiovascular disease (e.g., coronary artery disease, stroke, arrhythmias, congestive heart failure, uncontrolled hypertension) () • During or within… (etiqueta de Fentermina, Contraindicaciones)

  • IsoniazidaantibióticoGrave

    …cardiovascular disease (e.g., coronary artery disease, stroke, arrhythmias, congestive heart failure, uncontrolled hypertension) • During or within 14 days following the administration of monoamine oxidase inhibitors • Hyperthyroidism • Glaucoma • Agitated states • History of drug abuse • Pregnancy [ see Use in Specific Populations () ] • Nursing [ see Use in Specific… (etiqueta de Fentermina, Contraindicaciones)

  • Isoprenalina (isoproterenol)agonista beta-adrenérgicoGrave

    …states • History of drug abuse • Pregnancy [ see Use in Specific Populations () ] • Nursing [ see Use in Specific Populations ( 8.3 ) ] • Known hypersensitivity, or idiosyncrasy to the sympathomimetic amines • History of cardiovascular disease (e.g., coronary artery disease, stroke, arrhythmias, congestive heart failure, uncontrolled hypertension) () • During or within… (etiqueta de Fentermina, Contraindicaciones)

  • Levosalbutamolagonista beta-adrenérgicoGrave

    …states • History of drug abuse • Pregnancy [ see Use in Specific Populations () ] • Nursing [ see Use in Specific Populations ( 8.3 ) ] • Known hypersensitivity, or idiosyncrasy to the sympathomimetic amines • History of cardiovascular disease (e.g., coronary artery disease, stroke, arrhythmias, congestive heart failure, uncontrolled hypertension) () • During or within… (etiqueta de Fentermina, Contraindicaciones)

  • Levotiroxina y liotironinahormona tiroideaGrave

    Larger doses may produce serious or even life-threatening manifestations of toxicity, particularly when given in association with sympathomimetic amines such as those used for their anorectic effects. (etiqueta de Levotiroxina y liotironina, Advertencia en recuadro)

  • LinezolidantibióticoGrave

    …cardiovascular disease (e.g., coronary artery disease, stroke, arrhythmias, congestive heart failure, uncontrolled hypertension) • During or within 14 days following the administration of monoamine oxidase inhibitors • Hyperthyroidism • Glaucoma • Agitated states • History of drug abuse • Pregnancy [ see Use in Specific Populations () ] • Nursing [ see Use in Specific… (etiqueta de Fentermina, Contraindicaciones)

  • Liotironinahormona tiroideaGrave

    • Larger doses may produce serious or even life-threatening manifestations of toxicity, particularly when given in association with sympathomimetic amines such as those used for their anorectic effects [see Adverse Reactions (6) , Drug Interactions (7.7) , and Overdosage (10) ] . (etiqueta de Liotironina, Advertencia en recuadro)

  • Mepivacaínaanestésico localGrave

    Mepivacaine with epinephrine or other vasopressors should not be used concomitantly with ergot-type oxytocic drugs, because a severe persistent hypertension may occur. (etiqueta de Mepivacaína, Advertencias)

  • Metanfetaminaestimulante del SNCGrave

    Hypersensitivity reactions such as angioedema and anaphylactic reactions have been reported in patients treated with other amphetamine products [see Adverse Reactions ( 6 )]. taking monoamine oxidase inhibitors (MAOIs), or within 14 days following discontinuation of treatment with an MAOIs (including MAOIs such as linezolid or intravenous methylene blue), because… (etiqueta de Metanfetamina, Contraindicaciones)

  • Mirabegrónagonista beta-adrenérgicoGrave

    …states • History of drug abuse • Pregnancy [ see Use in Specific Populations () ] • Nursing [ see Use in Specific Populations ( 8.3 ) ] • Known hypersensitivity, or idiosyncrasy to the sympathomimetic amines • History of cardiovascular disease (e.g., coronary artery disease, stroke, arrhythmias, congestive heart failure, uncontrolled hypertension) () • During or within… (etiqueta de Fentermina, Contraindicaciones)

  • Oxibato de sodiodepresor del SNCGrave

    Many patients who received Xyrem during clinical trials in narcolepsy were receiving central nervous system stimulants [see Clinical Trials ( 14 )]. (etiqueta de Oxibato de sodio, Advertencia en recuadro)

  • OximetazolinadescongestionanteGrave

    …states • History of drug abuse • Pregnancy [ see Use in Specific Populations () ] • Nursing [ see Use in Specific Populations ( 8.3 ) ] • Known hypersensitivity, or idiosyncrasy to the sympathomimetic amines • History of cardiovascular disease (e.g., coronary artery disease, stroke, arrhythmias, congestive heart failure, uncontrolled hypertension) () • During or within… (etiqueta de Fentermina, Contraindicaciones)

  • PimozidaantipsicóticoGrave

    Pimozide should not be used in patients taking drugs that may, themselves, cause motor and phonic tics (e.g., pemoline, methylphenidate and amphetamines) until such patients have been withdrawn from these drugs to determine whether or not the drugs, rather than Tourette’s Disorder, are responsible for the tics. (etiqueta de Pimozida, Contraindicaciones)

  • PrometazinaantihistamínicoGrave

    Epinephrine Because of the potential for Promethazine to reverse epinephrine's vasopressor effect, epinephrine should NOT be used to treat hypotension associated with Promethazine Syrup overdose. (etiqueta de Prometazina, Interacciones medicamentosas)

  • Prometazina y dextrometorfanoantihistamínicoGrave

    Epinephrine – Because of the potential for promethazine to reverse epinephrine’s vasopressor effect, epinephrine should NOT be used to treat hypotension associated with Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution overdose. (etiqueta de Prometazina y dextrometorfano, Interacciones medicamentosas)

  • Vasopressors and resuscitation equipment should be immediately available in case of a severe reaction to protamine. (etiqueta de Protamina, Advertencia en recuadro)

  • PseudoefedrinadescongestionanteGrave

    …states • History of drug abuse • Pregnancy [ see Use in Specific Populations () ] • Nursing [ see Use in Specific Populations ( 8.3 ) ] • Known hypersensitivity, or idiosyncrasy to the sympathomimetic amines • History of cardiovascular disease (e.g., coronary artery disease, stroke, arrhythmias, congestive heart failure, uncontrolled hypertension) () • During or within… (etiqueta de Fentermina, Contraindicaciones)

  • Rasagilinainhibidor de la MAOGrave

    …cardiovascular disease (e.g., coronary artery disease, stroke, arrhythmias, congestive heart failure, uncontrolled hypertension) • During or within 14 days following the administration of monoamine oxidase inhibitors • Hyperthyroidism • Glaucoma • Agitated states • History of drug abuse • Pregnancy [ see Use in Specific Populations () ] • Nursing [ see Use in Specific… (etiqueta de Fentermina, Contraindicaciones)

  • Salbutamolagonista beta-adrenérgicoGrave

    …states • History of drug abuse • Pregnancy [ see Use in Specific Populations () ] • Nursing [ see Use in Specific Populations ( 8.3 ) ] • Known hypersensitivity, or idiosyncrasy to the sympathomimetic amines • History of cardiovascular disease (e.g., coronary artery disease, stroke, arrhythmias, congestive heart failure, uncontrolled hypertension) () • During or within… (etiqueta de Fentermina, Contraindicaciones)

  • Salmeterolagonista beta-adrenérgicoGrave

    …states • History of drug abuse • Pregnancy [ see Use in Specific Populations () ] • Nursing [ see Use in Specific Populations ( 8.3 ) ] • Known hypersensitivity, or idiosyncrasy to the sympathomimetic amines • History of cardiovascular disease (e.g., coronary artery disease, stroke, arrhythmias, congestive heart failure, uncontrolled hypertension) () • During or within… (etiqueta de Fentermina, Contraindicaciones)

  • Selegilinainhibidor de la MAOGrave

    …cardiovascular disease (e.g., coronary artery disease, stroke, arrhythmias, congestive heart failure, uncontrolled hypertension) • During or within 14 days following the administration of monoamine oxidase inhibitors • Hyperthyroidism • Glaucoma • Agitated states • History of drug abuse • Pregnancy [ see Use in Specific Populations () ] • Nursing [ see Use in Specific… (etiqueta de Fentermina, Contraindicaciones)

  • Terbutalinaagonista beta-adrenérgicoGrave

    …states • History of drug abuse • Pregnancy [ see Use in Specific Populations () ] • Nursing [ see Use in Specific Populations ( 8.3 ) ] • Known hypersensitivity, or idiosyncrasy to the sympathomimetic amines • History of cardiovascular disease (e.g., coronary artery disease, stroke, arrhythmias, congestive heart failure, uncontrolled hypertension) () • During or within… (etiqueta de Fentermina, Contraindicaciones)

  • Tizanidinarelajante muscularGrave

    Hypotension: monitor for signs and symptoms of hypotension, in particular in patients receiving concurrent antihypertensives; Zanaflex should not be used with other α 2 -adrenergic agonists ( 5.1 , 7.7 ) (etiqueta de Tizanidina, Advertencias y precauciones)

  • Tranilciprominainhibidor de la MAOGrave

    …cardiovascular disease (e.g., coronary artery disease, stroke, arrhythmias, congestive heart failure, uncontrolled hypertension) • During or within 14 days following the administration of monoamine oxidase inhibitors • Hyperthyroidism • Glaucoma • Agitated states • History of drug abuse • Pregnancy [ see Use in Specific Populations () ] • Nursing [ see Use in Specific… (etiqueta de Fentermina, Contraindicaciones)

  • Umeclidinio y vilanterolanticolinérgicoGrave

    …states • History of drug abuse • Pregnancy [ see Use in Specific Populations () ] • Nursing [ see Use in Specific Populations ( 8.3 ) ] • Known hypersensitivity, or idiosyncrasy to the sympathomimetic amines • History of cardiovascular disease (e.g., coronary artery disease, stroke, arrhythmias, congestive heart failure, uncontrolled hypertension) () • During or within… (etiqueta de Fentermina, Contraindicaciones)

  • Vibegrónagonista beta-adrenérgicoGrave

    …states • History of drug abuse • Pregnancy [ see Use in Specific Populations () ] • Nursing [ see Use in Specific Populations ( 8.3 ) ] • Known hypersensitivity, or idiosyncrasy to the sympathomimetic amines • History of cardiovascular disease (e.g., coronary artery disease, stroke, arrhythmias, congestive heart failure, uncontrolled hypertension) () • During or within… (etiqueta de Fentermina, Contraindicaciones)

Interacciones moderadas (113)

  • AcarbosaantidiabéticoModerada

    • A reduction in dose of insulin or oral hypoglycemic medication may be required in some patients. (etiqueta de Fentermina, Advertencias y precauciones)

  • Acetazolamidainhibidor de la anhidrasa carbónicaModerada

    Acetazolamide decreases urinary excretion of amphetamine and may enhance the magnitude and duration of their effect. (etiqueta de Acetazolamida, Interacciones medicamentosas)

  • AclidinioanticolinérgicoModerada

    Sympathomimetics, Methylxanthines, Steroids In clinical studies, concurrent administration of aclidinium bromide and other drugs commonly used in the treatment of COPD including sympathomimetics (short-acting beta 2 agonists), methylxanthines, and oral and inhaled steroids showed no increases in adverse drug reactions. (etiqueta de Aclidinio, Interacciones medicamentosas)

  • AlcoholAlcoholModerada

    • Concomitant alcohol use may result in an adverse drug reaction. (etiqueta de Fentermina, Advertencias y precauciones)

  • Alogliptinainhibidor de la DPP-4Moderada

    • A reduction in dose of insulin or oral hypoglycemic medication may be required in some patients. (etiqueta de Fentermina, Advertencias y precauciones)

  • Alogliptina y metforminainhibidor de la DPP-4Moderada

    • A reduction in dose of insulin or oral hypoglycemic medication may be required in some patients. (etiqueta de Fentermina, Advertencias y precauciones)

  • AlprazolambenzodiazepinaModerada

    Prescribe the lowest effective dosage; avoid or minimize concomitant use of CNS depressants and other substances associated with abuse, misuse, and addiction (e.g., opioid analgesics, stimulants); and advise patients on the proper disposal of unused drug. (etiqueta de Alprazolam, Advertencias y precauciones)

  • AmiodaronaantiarrítmicoModerada

    • Hypotension: Slow the infusion; as needed, add vasopressor drugs, positive inotropic agents, and volume expansion. (etiqueta de Amiodarona, Advertencias y precauciones)

  • Amitriptilinaantidepresivo tricíclicoModerada

    When amitriptyline is given with anticholinergic agents or sympathomimetic drugs, including epinephrine combined with local anesthetics, close supervision and careful adjustment of dosages are required. (etiqueta de Amitriptilina, Interacciones medicamentosas)

  • Anfepramonaestimulante del SNCModerada

    Risk of Abuse and Dependence Phentermine is related chemically and pharmacologically to amphetamine (d- and d l l-amphetamine) and other related stimulant drugs that have been extensively abused. (etiqueta de Fentermina, Advertencias y precauciones)

  • Armodafiniloestimulante del SNCModerada

    Risk of Abuse and Dependence Phentermine is related chemically and pharmacologically to amphetamine (d- and d l l-amphetamine) and other related stimulant drugs that have been extensively abused. (etiqueta de Fentermina, Advertencias y precauciones)

  • Bexagliflozinainhibidor de SGLT2Moderada

    • A reduction in dose of insulin or oral hypoglycemic medication may be required in some patients. (etiqueta de Fentermina, Advertencias y precauciones)

  • BortezomibModerada

    Management of orthostatic/postural hypotension may include adjustment of antihypertensive medications, hydration, and administration of mineralocorticoids and/or sympathomimetics. (etiqueta de Bortezomib, Advertencias y precauciones)

  • Brimonidina y timololagonista alfa-adrenérgicoModerada

    If necessary during surgery, the effects of beta-adrenergic blocking agents may be reversed by sufficient doses of adrenergic agonists. (etiqueta de Brimonidina y timolol, Advertencias y precauciones)

  • BupropiónantidepresivoModerada

    …medications that lower the seizure threshold (e.g., other bupropion products, antipsychotics, tricyclic antidepressants, theophylline, and systemic corticosteroids), metabolic disorders (e.g., hypoglycemia, hyponatremia, severe hepatic impairment, and hypoxia), or use of illicit drugs (e.g., cocaine) or abuse or misuse of prescription drugs such as CNS stimulants. (etiqueta de Bupropión, Advertencias y precauciones)

  • Risk of Abuse and Dependence Phentermine is related chemically and pharmacologically to amphetamine (d- and d l l-amphetamine) and other related stimulant drugs that have been extensively abused. (etiqueta de Fentermina, Advertencias y precauciones)

  • Risk of Abuse and Dependence Phentermine is related chemically and pharmacologically to amphetamine (d- and d l l-amphetamine) and other related stimulant drugs that have been extensively abused. (etiqueta de Fentermina, Advertencias y precauciones)

  • Risk of Abuse and Dependence Phentermine is related chemically and pharmacologically to amphetamine (d- and d l l-amphetamine) and other related stimulant drugs that have been extensively abused. (etiqueta de Fentermina, Advertencias y precauciones)

  • Risk of Abuse and Dependence Phentermine is related chemically and pharmacologically to amphetamine (d- and d l l-amphetamine) and other related stimulant drugs that have been extensively abused. (etiqueta de Fentermina, Advertencias y precauciones)

  • Canagliflozinainhibidor de SGLT2Moderada

    • A reduction in dose of insulin or oral hypoglycemic medication may be required in some patients. (etiqueta de Fentermina, Advertencias y precauciones)

  • Candesartánantagonista de los receptores de la angiotensina II (ARA-II)Moderada

    Very rarely, hypotension may be severe such that it may warrant the use of intravenous fluids and/or vasopressors. (etiqueta de Candesartán, Advertencias y precauciones)

  • CitalopramISRSModerada

    The risk is increased with concomitant use of other serotonergic drugs (including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, meperidine, methadone, tryptophan, buspirone, amphetamines, and St. (etiqueta de Citalopram, Advertencias y precauciones)

  • ClobazambenzodiazepinaModerada

    Prescribe the lowest effective dosage; avoid or minimize concomitant use of CNS depressants and other substances associated with abuse, misuse, and addiction (e.g., opioid analgesics, stimulants); and advise patients on the proper disposal of unused drug. (etiqueta de Clobazam, Advertencias y precauciones)

  • Clomipraminaantidepresivo tricíclicoModerada

    Close supervision and careful adjustment of dosage are required when clomipramine hydrochloride capsules are administered with anticholinergic or sympathomimetic drugs. (etiqueta de Clomipramina, Interacciones medicamentosas)

  • ClonazepambenzodiazepinaModerada

    Prescribe the lowest effective dosage; avoid or minimize concomitant use of CNS depressants and other substances associated with abuse, misuse, and addiction (e.g., opioid analgesics, stimulants); and advise patients on the proper disposal of unused drug. (etiqueta de Clonazepam, Advertencias)

  • ClorazepatobenzodiazepinaModerada

    Prescribe the lowest effective dosage; avoid or minimize concomitant use of CNS depressants and other substances associated with abuse, misuse, and addiction (e.g., opioid analgesics, stimulants); and advise patients on the proper disposal of unused drug. (etiqueta de Clorazepato, Advertencias)

  • ClordiazepóxidobenzodiazepinaModerada

    Prescribe the lowest effective dosage; avoid or minimize concomitant use of CNS depressants and other substances associated with abuse, misuse, and addiction (e.g., opioid analgesics, stimulants); and advise patients on the proper disposal of unused drug. (etiqueta de Clordiazepóxido, Advertencias)

  • Clordiazepóxido y clidiniobenzodiazepinaModerada

    Prescribe the lowest effective dosage; avoid or minimize concomitant use of CNS depressants and other substances associated with abuse, misuse, and addiction (e.g., opioid analgesics, stimulants); and advise patients on the proper disposal of unused drug. (etiqueta de Clordiazepóxido y clidinio, Advertencias)

  • Dapagliflozinainhibidor de SGLT2Moderada

    • A reduction in dose of insulin or oral hypoglycemic medication may be required in some patients. (etiqueta de Fentermina, Advertencias y precauciones)

  • Dapagliflozina y metforminainhibidor de SGLT2Moderada

    • A reduction in dose of insulin or oral hypoglycemic medication may be required in some patients. (etiqueta de Fentermina, Advertencias y precauciones)

  • Desipraminaantidepresivo tricíclicoModerada

    Close supervision and careful adjustment of dosage are required when this drug is given concomitantly with anticholinergic or sympathomimetic drugs. (etiqueta de Desipramina, Interacciones medicamentosas)

  • DesvenlafaxinaIRSNModerada

    The risk is increased with concomitant use of other serotonergic drugs (including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, meperidine, methadone, tryptophan, buspirone, amphetamines, and St. (etiqueta de Desvenlafaxina, Advertencias y precauciones)

  • Dexmetilfenidatoestimulante del SNCModerada

    Risk of Abuse and Dependence Phentermine is related chemically and pharmacologically to amphetamine (d- and d l l-amphetamine) and other related stimulant drugs that have been extensively abused. (etiqueta de Fentermina, Advertencias y precauciones)

  • DiazepambenzodiazepinaModerada

    Prescribe the lowest effective dosage; avoid or minimize concomitant use of CNS depressants and other substances associated with abuse, misuse, and addiction (e.g., opioid analgesics, stimulants); and advise patients on the proper disposal of unused drug. (etiqueta de Diazepam, Advertencias)

  • DicicloverinaanticolinérgicoModerada

    …drugs including dicyclomine hydrochloride: amantadine, antiarrhythmic agents of Class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. (etiqueta de Dicicloverina, Interacciones medicamentosas)

  • Digoxinaglucósido digitálicoModerada

    Sympathomimetics Epinephrine Can increase the risk of cardiac arrhythmias. (etiqueta de Digoxina, Interacciones medicamentosas)

  • Dorzolamida y timololinhibidor de la anhidrasa carbónicaModerada

    If necessary during surgery, the effects of beta-adrenergic blocking agents may be reversed by sufficient doses of adrenergic agonists. (etiqueta de Dorzolamida y timolol, Advertencias y precauciones)

  • DoxapramModerada

    Drug Interactions Administration of doxapram to patients who are receiving sympathomimetic or monoamine oxidase inhibiting drugs may result in an additive pressor effect (see PRECAUTIONS, General ). (etiqueta de Doxapram, Interacciones medicamentosas)

  • Dulaglutidaagonista del receptor de GLP-1Moderada

    • A reduction in dose of insulin or oral hypoglycemic medication may be required in some patients. (etiqueta de Fentermina, Advertencias y precauciones)

  • DuloxetinaIRSNModerada

    The risk is increased with concomitant use of other serotonergic drugs (including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, meperidine, methadone, tryptophan, buspirone, amphetamines, and St. (etiqueta de Duloxetina, Advertencias y precauciones)

  • EfedrinasimpaticomiméticoModerada

    • Pr e ssor Effect with Concomitant Oxytocic Drugs : Pressor effect of sympathomimetic pressor amines is potentiated (5.1) (etiqueta de Efedrina, Advertencias y precauciones)

  • Empagliflozinainhibidor de SGLT2Moderada

    • A reduction in dose of insulin or oral hypoglycemic medication may be required in some patients. (etiqueta de Fentermina, Advertencias y precauciones)

  • Empagliflozina y metforminainhibidor de SGLT2Moderada

    • A reduction in dose of insulin or oral hypoglycemic medication may be required in some patients. (etiqueta de Fentermina, Advertencias y precauciones)

  • Ergotamina y cafeínaalcaloide ergóticoModerada

    Risk of Abuse and Dependence Phentermine is related chemically and pharmacologically to amphetamine (d- and d l l-amphetamine) and other related stimulant drugs that have been extensively abused. (etiqueta de Fentermina, Advertencias y precauciones)

  • EscitalopramISRSModerada

    The risk is increased with concomitant use of other serotonergic drugs (including triptans, tricyclic antidepressants, fentanyl, meperidine, methadone, lithium, tramadol, tryptophan, buspirone, amphetamines, and St. (etiqueta de Escitalopram, Advertencias y precauciones)

  • EsmololbetabloqueanteModerada

    Sympathomimetic drugs: Dose adjustment needed (7) (etiqueta de Esmolol, Interacciones medicamentosas)

  • EstazolambenzodiazepinaModerada

    Prescribe the lowest effective dosage; avoid or minimize concomitant use of CNS depressants and other substances associated with abuse, misuse, and addiction (e.g., opioid analgesics, stimulants); and advise patients on the proper disposal of unused drug. (etiqueta de Estazolam, Advertencias)

  • Exenatidaagonista del receptor de GLP-1Moderada

    • A reduction in dose of insulin or oral hypoglycemic medication may be required in some patients. (etiqueta de Fentermina, Advertencias y precauciones)

  • FluoxetinaISRSModerada

    The risk is increased with concomitant use of other serotonergic drugs (including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, meperidine, methadone, buspirone, amphetamines, and St. (etiqueta de Fluoxetina, Advertencias y precauciones)

  • FluvoxaminaISRSModerada

    The risk is increased with concomitant use of other serotonergic drugs (including triptans, tricyclic antidepressants, fentanyl, meperidine, methadone, lithium, tramadol, tryptophan, buspirone, amphetamines, and St. (etiqueta de Fluvoxamina, Advertencias y precauciones)

  • GlibenclamidasulfonilureaModerada

    • A reduction in dose of insulin or oral hypoglycemic medication may be required in some patients. (etiqueta de Fentermina, Advertencias y precauciones)

  • Glibenclamida y metforminasulfonilureaModerada

    • A reduction in dose of insulin or oral hypoglycemic medication may be required in some patients. (etiqueta de Fentermina, Advertencias y precauciones)

  • GlimepiridasulfonilureaModerada

    • A reduction in dose of insulin or oral hypoglycemic medication may be required in some patients. (etiqueta de Fentermina, Advertencias y precauciones)

  • GlipizidasulfonilureaModerada

    • A reduction in dose of insulin or oral hypoglycemic medication may be required in some patients. (etiqueta de Fentermina, Advertencias y precauciones)

  • Glipizida y metforminasulfonilureaModerada

    • A reduction in dose of insulin or oral hypoglycemic medication may be required in some patients. (etiqueta de Fentermina, Advertencias y precauciones)

  • Guanfacinaagonista alfa-adrenérgicoModerada

    In these cases, high-dosage guanfacine was discontinued; concomitant stimulant use was also reported, which may potentially increase hypertensive response upon abrupt discontinuation of guanfacine. (etiqueta de Guanfacina, Advertencias y precauciones)

  • Insulina aspartainsulinaModerada

    • A reduction in dose of insulin or oral hypoglycemic medication may be required in some patients. (etiqueta de Fentermina, Advertencias y precauciones)

  • Insulina degludecinsulinaModerada

    • A reduction in dose of insulin or oral hypoglycemic medication may be required in some patients. (etiqueta de Fentermina, Advertencias y precauciones)

  • Insulina detemirinsulinaModerada

    • A reduction in dose of insulin or oral hypoglycemic medication may be required in some patients. (etiqueta de Fentermina, Advertencias y precauciones)

  • Insulina glarginainsulinaModerada

    • A reduction in dose of insulin or oral hypoglycemic medication may be required in some patients. (etiqueta de Fentermina, Advertencias y precauciones)

  • Insulina lisproinsulinaModerada

    • A reduction in dose of insulin or oral hypoglycemic medication may be required in some patients. (etiqueta de Fentermina, Advertencias y precauciones)

  • • A reduction in dose of insulin or oral hypoglycemic medication may be required in some patients. (etiqueta de Fentermina, Advertencias y precauciones)

  • Ketaminadepresor del SNCModerada

    Sympathomimetics and Vasopressin : Sympathomimetics and vasopressin may enhance the sympathomimetic effects of ketamine [see Drug Interactions ( 7.2 )] . (etiqueta de Ketamina, Advertencias y precauciones)

  • LevomilnacipránIRSNModerada

    The risk is increased with concomitant use of other serotonergic drugs (including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, meperidine, methadone, tryptophan, buspirone, amphetamines, and St. (etiqueta de Levomilnaciprán, Advertencias y precauciones)

  • Levotiroxinahormona tiroideaModerada

    Sympathomimetics Concurrent use may of sympathomimetics and levothyroxine may increase the effects of sympathomimetics or thyroid hormone. (etiqueta de Levotiroxina, Interacciones medicamentosas)

  • Lidocaínaanestésico localModerada

    Concurrent administration of vasopressor drugs (for the treatment of hypotension related to obstetric blocks) and ergot-type oxytocic drugs may cause severe, persistent hypertension or cerebrovascular accidents. (etiqueta de Lidocaína, Interacciones medicamentosas)

  • Linagliptinainhibidor de la DPP-4Moderada

    • A reduction in dose of insulin or oral hypoglycemic medication may be required in some patients. (etiqueta de Fentermina, Advertencias y precauciones)

  • Linagliptina y metforminainhibidor de la DPP-4Moderada

    • A reduction in dose of insulin or oral hypoglycemic medication may be required in some patients. (etiqueta de Fentermina, Advertencias y precauciones)

  • Liraglutidaagonista del receptor de GLP-1Moderada

    • A reduction in dose of insulin or oral hypoglycemic medication may be required in some patients. (etiqueta de Fentermina, Advertencias y precauciones)

  • Lisdexanfetaminaestimulante del SNCModerada

    Risk of Abuse and Dependence Phentermine is related chemically and pharmacologically to amphetamine (d- and d l l-amphetamine) and other related stimulant drugs that have been extensively abused. (etiqueta de Fentermina, Advertencias y precauciones)

  • LorazepambenzodiazepinaModerada

    Prescribe the lowest effective dosage; avoid or minimize concomitant use of CNS depressants and other substances associated with abuse, misuse, and addiction (e.g., opioid analgesics, stimulants); and advise patients on the proper disposal of unused drug. (etiqueta de Lorazepam, Advertencias y precauciones)

  • MetforminabiguanidaModerada

    • A reduction in dose of insulin or oral hypoglycemic medication may be required in some patients. (etiqueta de Fentermina, Advertencias y precauciones)

  • MetildopaantihipertensivoModerada

    If hypotension does occur during anesthesia, it usually can be controlled by vasopressors. (etiqueta de Metildopa, Interacciones medicamentosas)

  • Metilfenidatoestimulante del SNCModerada

    Risk of Abuse and Dependence Phentermine is related chemically and pharmacologically to amphetamine (d- and d l l-amphetamine) and other related stimulant drugs that have been extensively abused. (etiqueta de Fentermina, Advertencias y precauciones)

  • Metolazonadiurético tiazídicoModerada

    Sympathomimetics Metolazone may decrease arterial responsiveness to norepinephrine, but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use. (etiqueta de Metolazona, Interacciones medicamentosas)

  • MiglitolantidiabéticoModerada

    • A reduction in dose of insulin or oral hypoglycemic medication may be required in some patients. (etiqueta de Fentermina, Advertencias y precauciones)

  • MilnacipránIRSNModerada

    The risk is increased with concomitant use of other serotonergic drugs (including triptans, tricyclic antidepressants, fentanyl, tramadol, meperidine, methadone, lithium, tryptophan, buspirone, amphetamines, and St. (etiqueta de Milnaciprán, Advertencias y precauciones)

  • MirtazapinaantidepresivoModerada

    The risk is increased with concomitant use of other serotonergic drugs (including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, amphetamines, and St. (etiqueta de Mirtazapina, Advertencias y precauciones)

  • Modafiniloestimulante del SNCModerada

    Risk of Abuse and Dependence Phentermine is related chemically and pharmacologically to amphetamine (d- and d l l-amphetamine) and other related stimulant drugs that have been extensively abused. (etiqueta de Fentermina, Advertencias y precauciones)

  • Naltrexona y bupropiónantagonista opioideModerada

    …tumor or infection, or metabolic disorders (e.g., hypoglycemia, hyponatremia, severe hepatic impairment, and hypoxia) excessive use of alcohol or sedatives, addiction to cocaine or stimulants, or withdrawal from sedatives patients with diabetes treated with insulin and/or oral diabetic medications (sulfonylureas and meglitinides) that may cause hypoglycemia concomitant… (etiqueta de Naltrexona y bupropión, Advertencias y precauciones)

  • NateglinidameglitinidaModerada

    • A reduction in dose of insulin or oral hypoglycemic medication may be required in some patients. (etiqueta de Fentermina, Advertencias y precauciones)

  • Nortriptilinaantidepresivo tricíclicoModerada

    Close supervision and careful adjustment of the dosage are required when Pamelor is used with other anticholinergic drugs and sympathomimetic drugs. (etiqueta de Nortriptilina, Interacciones medicamentosas)

  • Olanzapina y fluoxetinaantipsicóticoModerada

    The risk is increased with concomitant use of other serotonergic drugs (including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, meperidine, methadone, tryptophan, buspirone, amphetamines, and St. (etiqueta de Olanzapina y fluoxetina, Advertencias y precauciones)

  • Risk of Abuse and Dependence Phentermine is related chemically and pharmacologically to amphetamine (d- and d l l-amphetamine) and other related stimulant drugs that have been extensively abused. (etiqueta de Fentermina, Advertencias y precauciones)

  • OxazepambenzodiazepinaModerada

    Prescribe the lowest effective dosage; avoid or minimize concomitant use of CNS depressants and other substances associated with abuse, misuse, and addiction (e.g., opioid analgesics, stimulants); and advise patients on the proper disposal of unused drug. (etiqueta de Oxazepam, Advertencias)

  • ParoxetinaISRSModerada

    The risk is increased with concomitant use of other serotonergic drugs (including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, meperidine, methadone, tryptophan, buspirone, amphetamines, and St. (etiqueta de Paroxetina, Advertencias y precauciones)

  • PioglitazonatiazolidinedionaModerada

    • A reduction in dose of insulin or oral hypoglycemic medication may be required in some patients. (etiqueta de Fentermina, Advertencias y precauciones)

  • Pioglitazona y glimepiridatiazolidinedionaModerada

    • A reduction in dose of insulin or oral hypoglycemic medication may be required in some patients. (etiqueta de Fentermina, Advertencias y precauciones)

  • Pioglitazona y metforminatiazolidinedionaModerada

    • A reduction in dose of insulin or oral hypoglycemic medication may be required in some patients. (etiqueta de Fentermina, Advertencias y precauciones)

  • PropranololbetabloqueanteModerada

    Pharmacodynamic Drug-Drug Interactions Adrenergic Agonists: Beta-blockers may antagonize the antihypertensive effects of clonidine, and rebound hypertension may result if clonidine is withdrawn abruptly. (etiqueta de Propranolol, Interacciones medicamentosas)

  • Protriptilinaantidepresivo tricíclicoModerada

    Drug Interactions When protriptyline is given with anticholinergic agents or sympathomimetic drugs, including epinephrine combined with local anesthetics, close supervision and careful adjustment of dosages are required. (etiqueta de Protriptilina, Interacciones medicamentosas)

  • RepaglinidameglitinidaModerada

    • A reduction in dose of insulin or oral hypoglycemic medication may be required in some patients. (etiqueta de Fentermina, Advertencias y precauciones)

  • RitonavirantirretroviralModerada

    Anesthetic: meperidine ↓ meperidine/ ↑ normeperidine (metabolite) Dosage increase and long-term use of meperidine with ritonavir are not recommended due to the increased concentrations of the metabolite normeperidine which has both analgesic activity and CNS stimulant activity (e.g., seizures). (etiqueta de Ritonavir, Interacciones medicamentosas)

  • Saxagliptinainhibidor de la DPP-4Moderada

    • A reduction in dose of insulin or oral hypoglycemic medication may be required in some patients. (etiqueta de Fentermina, Advertencias y precauciones)

  • Saxagliptina y metforminainhibidor de la DPP-4Moderada

    • A reduction in dose of insulin or oral hypoglycemic medication may be required in some patients. (etiqueta de Fentermina, Advertencias y precauciones)

  • Semaglutidaagonista del receptor de GLP-1Moderada

    • A reduction in dose of insulin or oral hypoglycemic medication may be required in some patients. (etiqueta de Fentermina, Advertencias y precauciones)

  • SertralinaISRSModerada

    The risk is increased with concomitant use of other serotonergic drugs (including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, meperidine, methadone, tryptophan, buspirone, amphetamines, and St. (etiqueta de Sertralina, Advertencias y precauciones)

  • Sitagliptinainhibidor de la DPP-4Moderada

    • A reduction in dose of insulin or oral hypoglycemic medication may be required in some patients. (etiqueta de Fentermina, Advertencias y precauciones)

  • Sitagliptina y metforminainhibidor de la DPP-4Moderada

    • A reduction in dose of insulin or oral hypoglycemic medication may be required in some patients. (etiqueta de Fentermina, Advertencias y precauciones)

  • Solriamfetolestimulante del SNCModerada

    Risk of Abuse and Dependence Phentermine is related chemically and pharmacologically to amphetamine (d- and d l l-amphetamine) and other related stimulant drugs that have been extensively abused. (etiqueta de Fentermina, Advertencias y precauciones)

  • SotalolbetabloqueanteModerada

    Beta-2-Receptor Stimulants Beta-agonists such as albuterol, terbutaline and isoproterenol may have to be administered in increased dosages when used concomitantly with sotalol. (etiqueta de Sotalol, Interacciones medicamentosas)

  • SugammadexModerada

    The most commonly described clinical features in reports of anaphylaxis were dermatologic symptoms (including urticaria, rash, erythema, flushing and skin eruption); and clinically important hypotension often requiring the use of vasopressors for circulatory support. (etiqueta de Sugammadex, Advertencias y precauciones)

  • Circulatory Shock Circulatory shock with fever, severe hypotension, and confusion requiring intravenous fluid resuscitation and vasopressors has occurred within minutes to hours of re-challenge with trimethoprim-sulfamethoxazole products in patients with history of recent (days to weeks) exposure to sulfamethoxazole and trimethoprim. (etiqueta de Sulfametoxazol y trimetoprima, Advertencias)

  • TemazepambenzodiazepinaModerada

    Prescribe the lowest effective dosage; avoid or minimize concomitant use of CNS depressants and other substances associated with abuse, misuse, and addiction (e.g., opioid analgesics, stimulants); and advise patients on the proper disposal of unused drug. (etiqueta de Temazepam, Advertencias)

  • TimololbetabloqueanteModerada

    If necessary during surgery, the effects of beta-adrenergic blocking agents may be reversed by sufficient doses of adrenergic agonists. (etiqueta de Timolol, Advertencias y precauciones)

  • TiotropioanticolinérgicoModerada

    Concomitant Respiratory Medications SPIRIVA RESPIMAT has been used concomitantly with short-acting and long-acting sympathomimetic (beta-agonists) bronchodilators, methylxanthines, oral and inhaled steroids, antihistamines, mucolytics, leukotriene modifiers, cromones, and anti-IgE treatment without increases in adverse reactions. (etiqueta de Tiotropio, Interacciones medicamentosas)

  • Tirzepatidaagonista del receptor de GLP-1Moderada

    • A reduction in dose of insulin or oral hypoglycemic medication may be required in some patients. (etiqueta de Fentermina, Advertencias y precauciones)

  • TolcaponaModerada

    Drugs That Increase Catecholamines: Tolcapone did not influence the effect of ephedrine, an indirect sympathomimetic, on hemodynamic parameters or plasma catecholamine levels, either at rest or during exercise. (etiqueta de Tolcapona, Interacciones medicamentosas)

  • TriazolambenzodiazepinaModerada

    Prescribe the lowest effective dosage; avoid or minimize concomitant use of CNS depressants and other substances associated with abuse, misuse, and addiction (e.g., opioid analgesics, stimulants); and advise patients on the proper disposal of unused drug. (etiqueta de Triazolam, Advertencias y precauciones)

  • VenlafaxinaIRSNModerada

    The risk is increased with concomitant use of other serotonergic drugs (including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, meperidine, methadone, busipirone, amphetamines, and St. (etiqueta de Venlafaxina, Advertencias y precauciones)

  • VilazodonaISRSModerada

    The risk is increased with concomitant use of other serotonergic drugs (including triptans, tricyclic antidepressants, fentanyl, meperidine, methadone, lithium, tramadol, tryptophan, buspirone, amphetamines, and St. (etiqueta de Vilazodona, Advertencias y precauciones)

  • VortioxetinaantidepresivoModerada

    The risk is increased with concomitant use of other serotonergic drugs (including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, meperidine, methadone, buspirone, amphetamines, and St. (etiqueta de Vortioxetina, Advertencias y precauciones)

  • ZiprasidonaantipsicóticoModerada

    The risk is increased with concomitant use of other serotonergic drugs (including selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitors (SNRIs), triptans, tricyclic antidepressants, fentanyl, tramadol, meperidine, methadone, lithium, tryptophan, buspirone, amphetamines, and St. (etiqueta de Ziprasidona, Advertencias y precauciones)

Menciones leves (38)

  • AcebutololbetabloqueanteLeve

    A bronchodilator, such as theophylline or a β2-stimulant, should be made available in advance with instructions concerning its use. (etiqueta de Acebutolol, Advertencias)

  • AlmotriptántriptánLeve

    The safety and efficacy of combination therapy with phentermine and any other drug products for weight loss including prescribed drugs, over-the-counter preparations, and herbal products, or serotonergic agents such as selective serotonin reuptake inhibitors (e.g., fluoxetine, sertraline, fluvoxamine, paroxetine), have not been established. (etiqueta de Fentermina, Advertencias y precauciones)

  • AmantadinaanticolinérgicoLeve

    Drug Interactions Careful observation is required when amantadine hydrochloride is administered concurrently with central nervous system stimulants. (etiqueta de Amantadina, Interacciones medicamentosas)

  • Amoxapinaantidepresivo tricíclicoLeve

    The safety and efficacy of combination therapy with phentermine and any other drug products for weight loss including prescribed drugs, over-the-counter preparations, and herbal products, or serotonergic agents such as selective serotonin reuptake inhibitors (e.g., fluoxetine, sertraline, fluvoxamine, paroxetine), have not been established. (etiqueta de Fentermina, Advertencias y precauciones)

  • Severe reactions have required intervention with vasopressor agents and supportive measures. (etiqueta de Benzonatato, Advertencias)

  • Bromocriptinaagonista de la dopaminaLeve

    There are postmarketing reports of hypertension and tachycardia when bromocriptine was co-administered with sympathomimetic drugs (e.g., phenylpropanolamine and isometheptene) in postpartum women. (etiqueta de Bromocriptina, Interacciones medicamentosas)

  • Buspironafármaco serotoninérgicoLeve

    The safety and efficacy of combination therapy with phentermine and any other drug products for weight loss including prescribed drugs, over-the-counter preparations, and herbal products, or serotonergic agents such as selective serotonin reuptake inhibitors (e.g., fluoxetine, sertraline, fluvoxamine, paroxetine), have not been established. (etiqueta de Fentermina, Advertencias y precauciones)

  • Ciclobenzaprinarelajante muscularLeve

    The safety and efficacy of combination therapy with phentermine and any other drug products for weight loss including prescribed drugs, over-the-counter preparations, and herbal products, or serotonergic agents such as selective serotonin reuptake inhibitors (e.g., fluoxetine, sertraline, fluvoxamine, paroxetine), have not been established. (etiqueta de Fentermina, Advertencias y precauciones)

  • Dextrometorfanofármaco serotoninérgicoLeve

    The safety and efficacy of combination therapy with phentermine and any other drug products for weight loss including prescribed drugs, over-the-counter preparations, and herbal products, or serotonergic agents such as selective serotonin reuptake inhibitors (e.g., fluoxetine, sertraline, fluvoxamine, paroxetine), have not been established. (etiqueta de Fentermina, Advertencias y precauciones)

  • Dextrometorfano y quinidinafármaco serotoninérgicoLeve

    The safety and efficacy of combination therapy with phentermine and any other drug products for weight loss including prescribed drugs, over-the-counter preparations, and herbal products, or serotonergic agents such as selective serotonin reuptake inhibitors (e.g., fluoxetine, sertraline, fluvoxamine, paroxetine), have not been established. (etiqueta de Fentermina, Advertencias y precauciones)

  • Dihidroergotaminaalcaloide ergóticoLeve

    The safety and efficacy of combination therapy with phentermine and any other drug products for weight loss including prescribed drugs, over-the-counter preparations, and herbal products, or serotonergic agents such as selective serotonin reuptake inhibitors (e.g., fluoxetine, sertraline, fluvoxamine, paroxetine), have not been established. (etiqueta de Fentermina, Advertencias y precauciones)

  • Doxepinaantidepresivo tricíclicoLeve

    The safety and efficacy of combination therapy with phentermine and any other drug products for weight loss including prescribed drugs, over-the-counter preparations, and herbal products, or serotonergic agents such as selective serotonin reuptake inhibitors (e.g., fluoxetine, sertraline, fluvoxamine, paroxetine), have not been established. (etiqueta de Fentermina, Advertencias y precauciones)

  • EletriptántriptánLeve

    The safety and efficacy of combination therapy with phentermine and any other drug products for weight loss including prescribed drugs, over-the-counter preparations, and herbal products, or serotonergic agents such as selective serotonin reuptake inhibitors (e.g., fluoxetine, sertraline, fluvoxamine, paroxetine), have not been established. (etiqueta de Fentermina, Advertencias y precauciones)

  • Flibanserinadepresor del SNCLeve

    The safety and efficacy of combination therapy with phentermine and any other drug products for weight loss including prescribed drugs, over-the-counter preparations, and herbal products, or serotonergic agents such as selective serotonin reuptake inhibitors (e.g., fluoxetine, sertraline, fluvoxamine, paroxetine), have not been established. (etiqueta de Fentermina, Advertencias y precauciones)

  • FrovatriptántriptánLeve

    The safety and efficacy of combination therapy with phentermine and any other drug products for weight loss including prescribed drugs, over-the-counter preparations, and herbal products, or serotonergic agents such as selective serotonin reuptake inhibitors (e.g., fluoxetine, sertraline, fluvoxamine, paroxetine), have not been established. (etiqueta de Fentermina, Advertencias y precauciones)

  • Granisetrónfármaco que prolonga el intervalo QTLeve

    The safety and efficacy of combination therapy with phentermine and any other drug products for weight loss including prescribed drugs, over-the-counter preparations, and herbal products, or serotonergic agents such as selective serotonin reuptake inhibitors (e.g., fluoxetine, sertraline, fluvoxamine, paroxetine), have not been established. (etiqueta de Fentermina, Advertencias y precauciones)

  • IpratropioanticolinérgicoLeve

    ATROVENT HFA has been used concomitantly with other drugs, including sympathomimetic bronchodilators, methylxanthines, oral and inhaled steroids commonly used in the treatment of COPD. (etiqueta de Ipratropio, Interacciones medicamentosas)

  • LabetalolbetabloqueanteLeve

    Labetalol has also been reported to produce a false-positive test for amphetamine when screening urine for the presence of drugs using the commercially available assay methods. (etiqueta de Labetalol, Interacciones medicamentosas)

  • Litiofármaco serotoninérgicoLeve

    The safety and efficacy of combination therapy with phentermine and any other drug products for weight loss including prescribed drugs, over-the-counter preparations, and herbal products, or serotonergic agents such as selective serotonin reuptake inhibitors (e.g., fluoxetine, sertraline, fluvoxamine, paroxetine), have not been established. (etiqueta de Fentermina, Advertencias y precauciones)

  • NaratriptántriptánLeve

    The safety and efficacy of combination therapy with phentermine and any other drug products for weight loss including prescribed drugs, over-the-counter preparations, and herbal products, or serotonergic agents such as selective serotonin reuptake inhibitors (e.g., fluoxetine, sertraline, fluvoxamine, paroxetine), have not been established. (etiqueta de Fentermina, Advertencias y precauciones)

  • NefazodonaantidepresivoLeve

    The safety and efficacy of combination therapy with phentermine and any other drug products for weight loss including prescribed drugs, over-the-counter preparations, and herbal products, or serotonergic agents such as selective serotonin reuptake inhibitors (e.g., fluoxetine, sertraline, fluvoxamine, paroxetine), have not been established. (etiqueta de Fentermina, Advertencias y precauciones)

  • Ondansetrónfármaco que prolonga el intervalo QTLeve

    The safety and efficacy of combination therapy with phentermine and any other drug products for weight loss including prescribed drugs, over-the-counter preparations, and herbal products, or serotonergic agents such as selective serotonin reuptake inhibitors (e.g., fluoxetine, sertraline, fluvoxamine, paroxetine), have not been established. (etiqueta de Fentermina, Advertencias y precauciones)

  • Palonosetrónfármaco serotoninérgicoLeve

    The safety and efficacy of combination therapy with phentermine and any other drug products for weight loss including prescribed drugs, over-the-counter preparations, and herbal products, or serotonergic agents such as selective serotonin reuptake inhibitors (e.g., fluoxetine, sertraline, fluvoxamine, paroxetine), have not been established. (etiqueta de Fentermina, Advertencias y precauciones)

  • PerfenazinaantipsicóticoLeve

    If a vasopressor is needed, norepinephrine may be used. (etiqueta de Perfenazina, Advertencias)

  • The safety and efficacy of combination therapy with phentermine and any other drug products for weight loss including prescribed drugs, over-the-counter preparations, and herbal products, or serotonergic agents such as selective serotonin reuptake inhibitors (e.g., fluoxetine, sertraline, fluvoxamine, paroxetine), have not been established. (etiqueta de Fentermina, Advertencias y precauciones)

  • Propofoldepresor del SNCLeve

    These effects are responsive to discontinuation of DIPRIVAN, intravenous fluid administration, and/or vasopressor therapy. (etiqueta de Propofol, Advertencias y precauciones)

  • Prucalopridafármaco serotoninérgicoLeve

    The safety and efficacy of combination therapy with phentermine and any other drug products for weight loss including prescribed drugs, over-the-counter preparations, and herbal products, or serotonergic agents such as selective serotonin reuptake inhibitors (e.g., fluoxetine, sertraline, fluvoxamine, paroxetine), have not been established. (etiqueta de Fentermina, Advertencias y precauciones)

  • Ramelteónsedante-hipnóticoLeve

    In addition, in vitro data indicate that ramelteon does not cause false-positive results for benzodiazepines, opiates, barbiturates, cocaine, cannabinoids, or amphetamines in two standard urine drug screening methods in vitro . (etiqueta de Ramelteón, Advertencias y precauciones)

  • RizatriptántriptánLeve

    The safety and efficacy of combination therapy with phentermine and any other drug products for weight loss including prescribed drugs, over-the-counter preparations, and herbal products, or serotonergic agents such as selective serotonin reuptake inhibitors (e.g., fluoxetine, sertraline, fluvoxamine, paroxetine), have not been established. (etiqueta de Fentermina, Advertencias y precauciones)

  • SumatriptántriptánLeve

    The safety and efficacy of combination therapy with phentermine and any other drug products for weight loss including prescribed drugs, over-the-counter preparations, and herbal products, or serotonergic agents such as selective serotonin reuptake inhibitors (e.g., fluoxetine, sertraline, fluvoxamine, paroxetine), have not been established. (etiqueta de Fentermina, Advertencias y precauciones)

  • The safety and efficacy of combination therapy with phentermine and any other drug products for weight loss including prescribed drugs, over-the-counter preparations, and herbal products, or serotonergic agents such as selective serotonin reuptake inhibitors (e.g., fluoxetine, sertraline, fluvoxamine, paroxetine), have not been established. (etiqueta de Fentermina, Advertencias y precauciones)

  • TapentadolopioideLeve

    The safety and efficacy of combination therapy with phentermine and any other drug products for weight loss including prescribed drugs, over-the-counter preparations, and herbal products, or serotonergic agents such as selective serotonin reuptake inhibitors (e.g., fluoxetine, sertraline, fluvoxamine, paroxetine), have not been established. (etiqueta de Fentermina, Advertencias y precauciones)

  • TiagabinaanticonvulsivoLeve

    In most cases, patients were using concomitant medications (antidepressants, antipsychotics, stimulants, narcotics) that are thought to lower the seizure threshold. (etiqueta de Tiagabina, Advertencias)

  • TramadolopioideLeve

    The safety and efficacy of combination therapy with phentermine and any other drug products for weight loss including prescribed drugs, over-the-counter preparations, and herbal products, or serotonergic agents such as selective serotonin reuptake inhibitors (e.g., fluoxetine, sertraline, fluvoxamine, paroxetine), have not been established. (etiqueta de Fentermina, Advertencias y precauciones)

  • The safety and efficacy of combination therapy with phentermine and any other drug products for weight loss including prescribed drugs, over-the-counter preparations, and herbal products, or serotonergic agents such as selective serotonin reuptake inhibitors (e.g., fluoxetine, sertraline, fluvoxamine, paroxetine), have not been established. (etiqueta de Fentermina, Advertencias y precauciones)

  • TrazodonaantidepresivoLeve

    The safety and efficacy of combination therapy with phentermine and any other drug products for weight loss including prescribed drugs, over-the-counter preparations, and herbal products, or serotonergic agents such as selective serotonin reuptake inhibitors (e.g., fluoxetine, sertraline, fluvoxamine, paroxetine), have not been established. (etiqueta de Fentermina, Advertencias y precauciones)

  • Trimipraminaantidepresivo tricíclicoLeve

    The safety and efficacy of combination therapy with phentermine and any other drug products for weight loss including prescribed drugs, over-the-counter preparations, and herbal products, or serotonergic agents such as selective serotonin reuptake inhibitors (e.g., fluoxetine, sertraline, fluvoxamine, paroxetine), have not been established. (etiqueta de Fentermina, Advertencias y precauciones)

  • ZolmitriptántriptánLeve

    The safety and efficacy of combination therapy with phentermine and any other drug products for weight loss including prescribed drugs, over-the-counter preparations, and herbal products, or serotonergic agents such as selective serotonin reuptake inhibitors (e.g., fluoxetine, sertraline, fluvoxamine, paroxetine), have not been established. (etiqueta de Fentermina, Advertencias y precauciones)

Compruebe Fentermina frente a todo lo que toma. Añada su lista completa; todos los pares se comprueban a la vez.

Abrir en el verificador

No es un consejo médico. La gravedad refleja la redacción de la etiqueta, no sus circunstancias. Una señal «grave» puede ser algo habitual bajo supervisión y una «leve» puede ser importante a dosis altas. Consulte a un farmacéutico.